Ibrahim Nassour, MD, MSCS, FSSO, FACS
Assistant Professor
On This Page
About Ibrahim Nassour
As a University of Florida Health surgical oncologist, I also serve as an assistant professor of surgery in the UF Division of Surgical Oncology. I specialize in gastrointestinal, pancreatic, liver and biliary cancers, with expertise in robotic pancreaticobiliary surgery and advanced regional cancer therapies.
I am honored to hold several leadership roles within the UF Department of Surgery, including director of robotic surgery, chair of the Robotic Steering Committee, director of Advanced Regional Cancer Therapies, assistant chair for performance improvement and physician director of quality. I also serve as the Commission on Cancer liaison physician and a UF Faculty Senate member.
I developed a comprehensive robotic surgical oncology program at UF Health, expanding the use of minimally invasive approaches for complex oncologic procedures, including robotic pancreaticoduodenectomy (Whipple procedure). I have also led the broader expansion of robotic surgery across the department of surgery and established two new clinical service lines at UF Health: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in 2021 and hepatic artery infusion (HAI) pump therapy in 2026.
I completed my surgical training at Johns Hopkins and UT Southwestern, earned a master’s degree in clinical and translational science, and completed advanced fellowship training in complex general surgical oncology at UPMC. My research focuses on minimally invasive and robotic surgery, neoadjuvant therapy for pancreaticobiliary cancers, and clinical trials incorporating liquid biopsies and adaptive neoadjuvant treatment strategies to optimize cancer care. My scholarly work has resulted in more than 100 peer-reviewed publications and book contributions.
I am double board certified by the American Board of Surgery in general surgery and complex general surgical oncology. I am a member of the Florida Medical Association, Society of Surgical Oncology, Americas Hepato-Pancreato-Biliary Association and American College of Surgeons.
Accomplishments
Teaching Profile
Courses Taught
-
MDC7600 – Surgery Clerkship
College of Medicine
Board Certifications
-
Complex General Surgical OncologyAmerican Board of Surgery
-
General SurgeryAmerican Board of Surgery
Clinical Profile
Specialties
- Cancer
- Surgical Oncology
Areas of Interest
- Bile Duct Stricture
- Cancer Treatment Information
- Cholangiocarcinoma
- Focal Therapy for Prostate Cancer
- Gastrointestinal Cancer
- Gastrointestinal Oncology Surgery
- Liver Metastases
- Malignant Mesothelioma
- Pancreatic Cancer
- Pancreatic Cancer Surgery
- Pancreatitis
- Peritoneal Carcinomatosis
- Robotic Surgery
- Small Bowel Resection
- Stomach Cancer
- The Whipple Procedure
Research Profile
0000-0002-9845-1074
Areas of Interest
- Clinical trials in gastrointestinal malignancies – colorectal, pancreas, esophagogastric, hepatobiliary, neuroendocrine tumors.
- Extrahepatic cholangiocarcinoma
- GIST
- Gastric cancer
- Laparoscopic surgery
- Liquid biopsies
- Liver metastasis- colorectal, neuroendocrine and other non-colorectal non-neuroendocrine metastasis
- Neoadjuvant therapy in the management of pancreato-biliary cancers
- Pancreatic cyst (Cystadenoma, Mucinous Cystic Neoplasm, Intraductal Papillary Mucinous Neoplasm)
- Pancreatic neuroendocrine
- Peritoneal surface malignancies
- Robotic Surgery
- Small bowel cancer
Publications
Academic Articles
Grants
-
A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
Active
- Role:
- Principal Investigator
- Funding:
- NRG ONCOLOGY FOU via NATL INST OF HLTH NCI
-
Utilizing navigation and education to improve NCCN guideline-driven care quality for patients with gastric and gastroesophageal junction malignancy in regions of Florida
Active
- Role:
- Principal Investigator
- Funding:
- MOUNT SINAI MEDICAL CTR via FL DEPT OF HLTH
-
Optimal Perioperative Therapy For Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial
- Role:
- Principal Investigator
- Funding:
- NRG ONCOLOGY FOU via NATL INST OF HLTH NCI
-
Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Active
- Role:
- Principal Investigator
- Funding:
- NRG ONCOLOGY FOU via NATL INST OF HLTH NCI
Education
-
Fellowship in Complex General Surgical Oncology
University of Pittsburgh Medical Center
-
Master of Science in Clinical and Translational Science
University of Texas Southwestern
-
Residency in General Surgery
University of Texas Southwestern Medical Center
-
Residency in General Surgery
Johns Hopkins Hospital
-
Research fellowship
University of Pittsburgh Medical Center
-
Medical Degree
American University of Beirut
Contact Details
- Business:
- (352) 594-5132
- Business:
- ibrahimnassour@ufl.edu